Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen

Gianfilippo Bertelli, Mario Valenzano, Sergio Costantini, Roberto Rissone, Catia Angiolini, Alessandra Signorini, Claudio Gustavino

Research output: Contribution to journalArticle

Abstract

Objectives. Sonohysterography (SHG) has been proposed as a useful tool for the surveillance of the endometrium in patients receiving tamoxifen. This study aimed to assess the value of SHG in asymptomatic patients who would have been biopsy candidates because of abnormal transvaginal ultrasound (TVUS) results. Methods. The study population included postmenopausal breast cancer patients receiving adjuvant tamoxifen who had asymptomatic abnormalities at TVUS (endometrial thickness ≥8 mm or endometrial echo not adequately visualized). SHG was performed with an Aloka SSD 680 system using a 5-MHz vaginal probe, with sterile saline solution as contrast medium. Results. Forty-one patients entered the study. A regular endometrial echo was identified by SHG in 9 patients (21.9%). Histology was obtained in the remaining 32 patients with positive (n = 27, 65.8%) or unsuccessful (n = 5, 12.2%) SHG. Benign polyps (n = 15, 36.6%) and endometrial atrophy (n = 14, 34.1%) were the most common findings; 3 patients (7.3%) had simple hyperplasia. Conclusions. Breast cancer patients with asymptomatic, tamoxifen-associated TVUS abnormalities have little additional benefit from SHG. More than 2/3 remain candidates for biopsy, which usually yields benign or insignificant findings. (C) 2000 Academic Press.

Original languageEnglish
Pages (from-to)275-277
Number of pages3
JournalGynecologic Oncology
Volume78
Issue number3 I
DOIs
Publication statusPublished - 2000

Keywords

  • Adjuvant hormone treatment of
  • Adverse effects
  • Breast cancer
  • Endometrial cancer
  • Sonohysterography
  • Tamoxifen
  • Transvaginal ultrasound

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Fingerprint Dive into the research topics of 'Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen'. Together they form a unique fingerprint.

  • Cite this

    Bertelli, G., Valenzano, M., Costantini, S., Rissone, R., Angiolini, C., Signorini, A., & Gustavino, C. (2000). Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen. Gynecologic Oncology, 78(3 I), 275-277. https://doi.org/10.1006/gyno.2000.5876